Managers / Q2 2025 · view latest →
BARD ASSOCIATES INC
CIK 0001105907 · 233 SOUTH WACKER DRIVE, SUITE 4400, CHICAGO, IL, 60606 · 3127829600
Summary
Bard Associates Inc reported $311M in U.S.-listed holdings across 173 positions for Q2 2025.
Its largest position, ENSG, represents 4.2% of the portfolio.
Compared with Q1 2025, the fund opened 11 new positions and exited 17.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 72.0% · $224M
- ETP · 13.9% · $43M
- REIT · 7.1% · $22M
- Closed-End Fund · 3.6% · $11M
- Other · 1.8% · $6M
- Other · 1.7% · $5M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| OROR ROYALTIES INC | NEW | +195.9K | 195.9K | +$5M | $5M |
| TGENTECOGEN INC NEW | NEW | +623.6K | 623.6K | +$4M | $4M |
| JANUS DETROIT STR TR | NEW | +78.9K | 78.9K | +$4M | $4M |
| AEHRAEHR TEST SYS | NEW | +194.5K | 194.5K | +$3M | $3M |
| ACNTASCENT INDUSTRIES CO | NEW | +172.1K | 172.1K | +$2M | $2M |
| INUVINUVO INC | NEW | +389.6K | 389.6K | +$2M | $2M |
| NEUROONE MED TECHNOLOGIES CO | NEW | +1.85M | 1.85M | +$1M | $1M |
| PMNTPERFECT MOMENT LTD | NEW | +4.40M | 4.40M | +$1M | $1M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2025
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $398M | 293 | May 8, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $389M | 241 | Feb 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $377M | 160 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $311M | 173 | Aug 5, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $268M | 179 | May 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $294M | 180 | Feb 6, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $293M | 177 | Nov 6, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $261M | 172 | Aug 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $278M | 176 | May 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $263M | 173 | Feb 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $242M | 187 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $258M | 185 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $242M | 190 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $232M | 194 | Feb 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $222M | 187 | Nov 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $234M | 182 | Aug 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $283M | 185 | May 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $304M | 181 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $296M | 176 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $306M | 174 | Aug 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $277M | 158 | May 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $253M | 152 | Feb 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $189M | 153 | Nov 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $180M | 154 | Aug 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $136M | 157 | May 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $197M | 165 | Feb 13, 2020 | RESTATEMENT | changes · EDGAR ↗ |
| Q3 2019 | $197M | 167 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $200M | 163 | Aug 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $198M | 168 | May 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $173M | 170 | Feb 13, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.